PTC Therapeutics Inc (NASDAQ:PTCT)

55.01
Delayed Data
As of May 22
 -0.20 / -0.36%
Today’s Change
14.53
Today|||52-Week Range
78.72
+6.26%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close55.21
Today’s open55.73
Day’s range53.93 - 56.69
Volume1,054,336
Average volume (3 months)838,217
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-53.12%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book6.06

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.32-1.02%
MNKDMannkind Corp-0.11-2.38%
GLPGGalapagos NV-0.11-0.22%
MDCOMedicines Co-0.39-1.42%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers